retinamidobenzyl glucuronide

03/01/1999 - "Tumor multiplicity was also markedly decreased in the 4-HPRCG treated rats. "
03/01/1999 - "At 80 days post DMBA intubation the control rats had an average of 1.43 tumors/rat compared to 0.71 and 0.36 tumors/rat in the 4-HPROG and 4-HPRCG respectively. "
03/01/1999 - "At 80 days post DMBA-intubation, tumor incidence was 57% and 27% in the 4-HPROG and 4-HPRCG treated rats, respectively. "
03/01/1999 - "Tumor latency was 15% longer in rats fed 2 mmol/kg diet of 4-HPRCG as compared to 4-HPROG. "
05/01/2005 - "The results of this study show that 4-HPRCG is an effective chemotherapeutic agent that caused 49% regression of DMBA-induced mammary tumors in rats, while showing almost no side-effects that are often observed with other natural or synthetic retinoids, such as a reduction in blood retinol level, elevation in blood triglyceride (TG) level, and decrease in bone mineral content (BMC). "

05/01/2005 - "These results suggest that 4-HPRCG should be considered as a better candidate for breast cancer treatment."